Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Misoprostol Administration Before Elective Caesarean Section to Reduce the Risk of Respiratory Morbidity in Newborns

NCT06946914 is registered in ClinicalTrials.gov with Kafrelsheikh University as lead sponsor.

NCT NCT06946914
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06946914 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Misoprostol Administration Before Elective Caesarean Section to Reduce the Risk of Respiratory Morbidity in Newborns
Lead sponsor
Kafrelsheikh University
Phase
Phase 4
Overall status
Recruiting
Start date
June 1, 2024
Completion date
August 1, 2025
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

caesarean section, misoprostol, respiratory distress syndrome (rds) of neonate